Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-26 @ 3:02 AM
Study NCT ID:
NCT01447420
Status:
COMPLETED
Last Update Posted:
2016-07-25
First Post:
2011-10-04
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02
Start Date Type:
None
Primary Completion Date:
2012-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-04
First Submit QC Date:
None
Study First Post Date:
2011-10-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-05-18
Results First Submit QC Date:
None
Results First Post Date:
2016-06-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-24
Last Update Post Date:
2016-07-25
Last Update Post Date Type:
ESTIMATED